Seller record · Telehealth service

AquaVita

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S3, pharmacy identification: The pages say medication comes from FDA-regulated pharmacies and partner pharmacies nationwide, and no pharmacy is named in the footer, the answers, the terms, the privacy policy or the purchase terms. 2 more criteria also fail; see the table below.

At a glance

AquaVitaTelehealth service

5/8criteria passed

Price: Semaglutide $215 for one month, tirzepatide $320
Sells: compounded semaglutide, compounded tirzepatide, NAD+ injection, and 2 more
FDA letters: None on file

Visit AquaVita See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A California medspa's telehealth program selling compounded semaglutide and tirzepatide by the month or by three months, with NAD+, glutathione and Lipo-B injection vials, in five states. It names no filling pharmacy, and its answers page says the plans include FDA-approved medications.

Operating entity AquaVita, Inc.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	AquaVita's website; AquaVita's compounded semaglutide page
S2	Prescription gating	PASS	AquaVita's eligibility page; AquaVita's compounded semaglutide product page
S3	Pharmacy identification	FAIL	AquaVita's website; AquaVita's platform terms and conditions; AquaVita's about page
S4	Compounding disclosure	FAIL	AquaVita's weight loss program FAQ; AquaVita's shop page; AquaVita's compounded semaglutide product page
S5	Analytical documentation	FAIL	AquaVita's shop page; AquaVita's compound semaglutide safety information page
S6	Business address	PASS	AquaVita's platform terms and conditions; AquaVita's privacy policy; AquaVita's contact page
S7	Price disclosure	PASS	AquaVita's shop page; AquaVita's reorder page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed medical provider conducts a telehealth good faith exam to assess eligibility before issuing any prescription, and the product pages require a video consultation with a provider before approval.Source: AquaVita's website; AquaVita's compounded semaglutide page.

S2PASSThe order button opens an eligibility check whose first screen asks the buyer's state, and the product page lists the intake forms before payment.Source: AquaVita's eligibility page; AquaVita's compounded semaglutide product page.

S3FAILThe pages say medication comes from FDA-regulated pharmacies and partner pharmacies nationwide, and no pharmacy is named in the footer, the answers, the terms, the privacy policy or the purchase terms.Source: AquaVita's website; AquaVita's platform terms and conditions; AquaVita's about page.

S4FAILThe answers page says the weight loss plans include FDA-approved medications, while every drug on sale is compounded. The footer and product pages state that compounded medications are not FDA-approved, which does not withdraw the claim.Source: AquaVita's weight loss program FAQ; AquaVita's shop page; AquaVita's compounded semaglutide product page.

S5FAILNo certificate of analysis or lot document is published on the product pages, the safety information pages or the policies.Source: AquaVita's shop page; AquaVita's compound semaglutide safety information page.

S6PASSAquaVita, Inc., named in the terms and the privacy policy, at 23321 El Toro Rd Suite G, Lake Forest, CA, printed in the footer of every page.Source: AquaVita's platform terms and conditions; AquaVita's privacy policy; AquaVita's contact page.

S7PASSCompounded semaglutide at $215 for a one-month supply or $600 for three months, and compounded tirzepatide at $320 or $900. NAD+ at $599 and glutathione at $295 for a ten-injection vial, and Lipo-B at $275. The reorder page prints continuation plans at $275 for 4 weeks and $650 for 12 weeks.Source: AquaVita's shop page; AquaVita's reorder page.

S8PASSNo FDA warning letter names AquaVita or AquaVita, Inc., and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, NAD+ injection, glutathione injection, Lipo-B (MIC+B12) injection.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells NAD+Who sells glutathione

Visit AquaVita

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.